Vimarsana
Biggest News Aggregation in the World

Page 20 - Evoke Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evoke Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evoke Pharma Today - Breaking & Trending Today

Evoke Pharma (NASDAQ:EVOK) Research Coverage Started at StockNews.com - Vimarsana News

Evoke Pharma (NASDAQ:EVOK) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Rating) in a note issued to investors on Saturday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. Evoke Pharma stock opened at $0.26 on Friday. Evoke Pharma has a one year low of $0.23 and a one year high of […]

Evoke Pharma, Inc. (EVOK) CEO David Gonyer on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Evoke Pharma, Inc. (EVOK) CEO David Gonyer on Q1 2022 Results - Earnings Call Transcript

Evoke Pharma, Inc. EVOK Q1 2022 Earnings Conference Call May 10, 2022, 4:30 PM ET Company Participants David Gonyer – Chief Executive Officer Chris Quesenberry – Chief Commercial Officer,...

Evoke Pharma, Inc. (NASDAQ:EVOK) Sees Significant Decline in Short Interest - Vimarsana News

Evoke Pharma, Inc. (NASDAQ:EVOK) Sees Significant Decline in Short Interest

Evoke Pharma, Inc. (NASDAQ:EVOK – Get Rating) was the recipient of a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 88,200 shares, a decrease of 37.5% from the March 31st total of 141,200 shares. Based on an average trading volume of 106,600 shares, the […]

Evoke Pharma, Inc. (EVOK) CEO Dave Gonyer on Q4 2021 Results - Earnings Call Transcript - Vimarsana News

Evoke Pharma, Inc. (EVOK) CEO Dave Gonyer on Q4 2021 Results - Earnings Call Transcript

Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2021 Earnings Conference Call March 8, 2022, 4:30 PM ET Company Participants Dave Gonyer – Chief Executive Officer Matt D’Onfrio – Chief Business Officer...

Zogenix : Amendment to Annual Report (Form 10-K/A) - Vimarsana News

Zogenix : Amendment to Annual Report (Form 10-K/A)

10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM ... | March 7, 2022